Original_edited.jpg

From innovation to therapeutic care
Go faster for Sickle Cell Disease patients

GR.jpg

INNOVHEM

A based-Genopole company founded on breakthrough innovation, 

INNOVHEM is developing solutions that will improve the medical care of the most common genetic disease over the world, sickle cell disease.

Our Mission

famille_edited_edited.jpg

Transform clinical care to improve patients quality of life

Our proposition

Combining innovative biomarkers with AI

Combining biomarkers adapted to Red Blood Cell diseases with AI, 

INNOVHEM is developping solutions, which make possible to optimize the care of patients: 

  • Improving the development of effective treatments

  • Offering personalized therapy for each patients

The Biomarkers

the method fbycell.png

 Fetal Hemoglobin per Red Blood Cell

- Related to the pathophysilogy of Sickle Cell Disease
- Accurate

The hemolysis.png

A new method to dose intra-vascular hemolysis

- Direct

- Accurate

The Team

A leadership on Sickle Cell Disease

WhatsApp Image 2021-11-17 at 12.22.35 1.jpeg

Marie Cambot

Pablo Bartolucci.jpg

Pablo Bartolucci

Photo%20Laura%20Bencheikh_edited.jpg

Laura Bencheikh

Project Manager

Partenaires et Soutiens

France Biotech.png
Lafrenchtech paris saclay.jfif
logo-CMJN-signature.jpg
WILCO-LOGO_COULEURS-signature-FR-MEDIUM.
MEDICEN.png
bpifrance-logo.png
Challenge +2.png

News

  • INNOVHEM is very pleased to announce the start of a preclinical Investigator Sponsored Trial with funding support by Jazz Pharmaceuticals, to support the development of new treatments for sickle cell disease

November, 27, 2020

Locations

Headquarter

Headquarter INNOVHEM.png

4 rue Pierre Fontaine
91000 EVRY-COURCOURONNES
FRANCE

Laboratory

Labo INNOVHEM.png

Bâtiment Félix Reyes, 
5 rue Gustave Eiffel
94000 Créteil
FRANCE